📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Syncom Formulations Q3 Net Profit Rises 47% YoY to ₹18.86 Cr; Margins Expand
Syncom Formulations (India) Limited reported a strong bottom-line performance for Q3 FY26, with net profit rising 47.4% YoY to ₹18.86 crore. This growth comes despite a 9.8% YoY decline in revenue from operations, which stood at ₹114.59 crore. The profitability surge was largely due to a sharp 37.8% reduction in raw material costs, significantly improving operating margins. Additionally, the company is facing a legal challenge regarding a ₹5.44 crore GST demand, which it plans to appeal.
Key Highlights
Standalone Net Profit increased 47.4% YoY to ₹18.86 crore from ₹12.79 crore.
Revenue from operations declined 9.8% YoY to ₹114.59 crore compared to ₹127.03 crore.
Raw material costs decreased significantly to ₹47.45 crore from ₹76.26 crore YoY, driving margin expansion.
Basic and Diluted EPS improved to ₹0.23 from ₹0.14 in the corresponding quarter last year.
Company disclosed a legal contest against a ₹5.44 crore GST demand involving ineligible Input Tax Credit.
💼 Action for Investors
Investors should focus on the significant margin improvement driven by lower input costs, while monitoring if the company can reverse the slight decline in top-line revenue. The pending GST litigation is a minor risk but should be tracked for potential impact on future cash flows.